Insulin vials vs. insulin cartridges: Further cost considerations

被引:9
|
作者
Al-Sharayri, Mohammad G. [1 ]
Alsabrah, Tariq M. [2 ]
Aljbori, Tareq M. [2 ]
Abu-Rumman, Ala'a Eddeen K. [2 ]
机构
[1] Univ York, York YO10 5DD, N Yorkshire, England
[2] Univ Bradford, Bradford BD7 1DP, W Yorkshire, England
关键词
Insulin; Vial; Cartridge; Wastage; Cost; PEN DEVICES;
D O I
10.1016/j.jsps.2012.07.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Scope: Many studies have provided evidence that favor the use of insulin pens over traditional insulin vials due to lower overall costs. The cost of insulin in the Royal Medical Services in Jordan is subject to other considerations due to the favorable tender prices and the process of dispensing of insulin within the Royal Medical Services. Objective: To highlight further cost considerations associated with the wastage in the use of insulin vials and cartridges in the Jordanian Royal Medical Services. Methods: Two random samples were selected from prescriptions dispensed for diabetic patients using insulin in January 2012 from the outpatient pharmacy in Al-Hussein Hospital, King Hussein Medical Center, Amman, Jordan. First sample was selected from prescriptions of patients using vials; second sample was selected from prescriptions of patients using pens and cartridges. Average costs for insulin and wastage were calculated per patient from the Royal Medical Services perspective. Results: The average direct cost per patient using vials was JD 5.197 and for those using cartridges was JD 22.135. The average wasted quantity per patient in the first sample was more than ten times that of the second sample. The cost of the average wasted quantity per patient in the first sample (1.022 JD) was more than the double that in the second sample (0.441 JD). Conclusion: Although, the direct cost of insulin per patient by using vials was lower than cartridges, there was a substantial reduction in the cost of wastage by using the cartridges in the Jordanian Royal Medical Services outpatients. (C) 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:225 / 227
页数:3
相关论文
共 50 条
  • [21] Incompatibility of insulin pens and cartridges - Reply
    Holleman, E
    Kuck, EM
    Vermeijden, JW
    Hoekstra, JBL
    LANCET, 1998, 351 (9105): : 833 - 834
  • [22] Medication errors associated with transition from insulin pens to insulin vials
    Trimble, Adam N.
    Bishop, Bryan
    Rampe, Nancy
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (02) : 70 - 75
  • [23] Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US
    Ray, J. A.
    Valentine, W. J.
    Roze, S.
    Nicklasson, L.
    Cobden, D.
    Raskin, P.
    Garber, A.
    Palmer, A. J.
    DIABETES OBESITY & METABOLISM, 2007, 9 (01): : 103 - 113
  • [24] Biphasic insulin aspart vs. human insulin in adolescents with type 1 diabetes on multiple daily insulin injections
    Mortensen, H
    Kocova, M
    Teng, LY
    Keiding, J
    Bruckner, I
    Philotheou, A
    PEDIATRIC DIABETES, 2006, 7 (01) : 4 - 10
  • [25] Comparison of Insulin Regimens with Basal Bolus vs. Mixed Insulin in Hospitalized Patients with Hyperglycemia
    Bellido, Virginia
    Suarez, Lorena
    Galiana Rodriguez, Maria
    Sanchez, Cecilia
    Dieguez, Marta
    Riestra, Maria
    Tuson, Carmen
    Casal, Florentino
    Delgado, Elias
    Menendez, Edelmiro
    DIABETES, 2014, 63 : A239 - A239
  • [26] Intensive insulin therapy vs. gene therapy with an unregulated insulin release: A comparison of efficacy
    Dong, HJ
    Morral, N
    McEvoy, R
    Meseck, M
    Mobbs, C
    Woo, SLC
    DIABETES, 2001, 50 : A93 - A93
  • [27] Insulin resistance vs. impaired insulin secretion in patients treated with novel antipsychotic drugs
    Kopf, D
    Gilles, M
    Rüsse, S
    Medlin, F
    Forst, T
    Pfützner, A
    Lehnert, H
    Deuschle, M
    DIABETOLOGIA, 2005, 48 : A225 - A225
  • [28] Comparing efficiency of insulin glargine vs. NPH insulin in patients with type 2 diabetes
    Kodela, B.
    Petrovic, J.
    Velickovic-Radovanovic, R.
    Lilic, R.
    Radenkovic, S.
    Dedovic, I
    VALUE IN HEALTH, 2007, 10 (06) : A254 - A254
  • [29] Continuation vs. Discontinuation of Insulin Secretagogues When Initiating Insulin in Type 2 Diabetes
    Swinnen, Sanne G.
    Dain, Marie-Paule
    Mauricio, Didac
    Devries, J. Hans
    Hoekstra, Joost B.
    Holleman, Frits
    DIABETES, 2010, 59 : A10 - A10
  • [30] Real life effectiveness of initiation of basal insulin in type 2 insulin naive diabetic patients: Giargine vs. Nph vs. detemir
    Sharplin, Peter
    Mehin, Nazanin
    Mcewan, Phil
    Tetlow, Tony
    DIABETES, 2007, 56 : A658 - A659